Project Details
Description
To evaluate the effect of denosumab on lumbar spine bone mineral density(BMD) Z-score at 12 months, as assessed by dual-energy X-ray absorptiometry (DXA), inchildren 2 to 17 years of age with osteogenesis imperfect.
| Acronym | LINK Denosumab Study in Osteogenesis Imperfecta |
|---|---|
| Status | Active |
| Effective start/end date | 28/01/15 → … |
| Links | https://clinicaltrials.gov/ct2/show/study/NCT02352753?show_locs=Y#locn |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.